Funder: National Institutes of Health (NIH)
Due Dates: October 21, 2025 (Renewal applications only)
Funding Amounts: Up to $400,000/year in direct costs (Federal share); 1:1 non-Federal matching required; max project period 2 years.
Summary: Supports late-stage preclinical research using adult stem cells to advance regenerative medicine therapies, limited to renewal applications from current RMIP awardees.
Key Information: Mandatory 1:1 non-Federal cost matching; only current RMIP-funded organizations are eligible.